Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Metabolic abnormalities in cardiac ischemia

M F Walsh1, L J Dominguez, J R Sowers

  • 1Division of Endocrinology, Metabolism, and Hypertension, Wayne State University School of Medicine, Detroit, Michigan, USA.

Cardiology Clinics
|November 1, 1995
PubMed
Summary

Metabolic abnormalities like insulin resistance are key risk factors for coronary heart disease. Addressing these issues through new treatments is crucial for reducing heart disease risk in vulnerable populations.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Author Correction: Feasibility of whole genome and transcriptome profiling in pediatric and young adult cancers.

Nature communications·2025
Same author

Prognostic Value of a Laboratory Index of Frailty in Older Patients Hospitalized for COVID-19: The COMEPA Study.

The Journal of frailty & aging·2024
Same author

Feasibility of whole genome and transcriptome profiling in pediatric and young adult cancers.

Nature communications·2022
Same author

The cortisol burden in elderly subjects with metabolic syndrome and its association with low-grade inflammation.

Aging clinical and experimental research·2019
Same author

Germline SAMD9 mutation in siblings with monosomy 7 and myelodysplastic syndrome.

Leukemia·2017
Same author

A case report of concurrent embryonal rhabdomyosarcoma and diffuse large B-cell lymphoma in an adult without identifiable cancer predisposition.

Biomarker research·2017

Area of Science:

  • Cardiology
  • Metabolic Syndrome
  • Epidemiology

Background:

  • Metabolic abnormalities are established risk factors for coronary heart disease (CHD).
  • These risk factors often coexist, frequently linked to insulin resistance and hyperinsulinemia.
  • Clinical studies reveal associations between metabolic risk factors and cardiovascular markers.

Purpose of the Study:

  • To explore the link between metabolic abnormalities and coronary heart disease risk.
  • To highlight the role of insulin resistance and hyperinsulinemia as common denominators.
  • To identify key metabolic factors and their relationships with cardiovascular markers.

Main Methods:

  • Review of epidemiologic and clinical studies.
  • Analysis of relationships among blood pressure, plasma insulin, lipids, and coagulation factors.

Related Experiment Videos

  • Examination of factors associated with hyperinsulinemia, including high-density lipoprotein and endothelial relaxing factors.

    • Main Results:

    • Insulin resistance and hyperinsulinemia are common in individuals with multiple metabolic risk factors.
    • Significant correlations exist between insulin levels, blood pressure, triglycerides, and cholesterol.
    • Hyperinsulinemia is associated with reduced levels of protective factors like high-density lipoprotein and plasminogen activators.

    Conclusions:

    • Interventions targeting insulin sensitivity and lipoprotein metabolism are vital for CHD risk reduction.
    • Pharmacologic and lifestyle strategies are essential for managing metabolic abnormalities.
    • Effective management is critical for individuals with hypertension, diabetes, or a family history of premature CHD.